Stock DNA
Pharmaceuticals & Biotechnology
CNY 35,359 Million (Large Cap)
19.00
NA
2.20%
-0.51
14.14%
2.66
Revenue and Profits:
Net Sales:
2,201 Million
(Quarterly Results - Jun 2025)
Net Profit:
576 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.98%
0%
-1.98%
6 Months
-4.89%
0%
-4.89%
1 Year
6.13%
0%
6.13%
2 Years
7.1%
0%
7.1%
3 Years
-2.37%
0%
-2.37%
4 Years
4.63%
0%
4.63%
5 Years
26.89%
0%
26.89%
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.32%
EBIT Growth (5y)
-1.21%
EBIT to Interest (avg)
66.81
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.59
Tax Ratio
6.63%
Dividend Payout Ratio
44.22%
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
28.47%
ROE (avg)
18.30%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.66
EV to EBIT
22.51
EV to EBITDA
18.26
EV to Capital Employed
4.35
EV to Sales
3.65
PEG Ratio
NA
Dividend Yield
2.20%
ROCE (Latest)
19.34%
ROE (Latest)
14.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Mar 2017
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.07%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
2,201.50
2,413.20
-8.77%
Operating Profit (PBDIT) excl Other Income
452.60
629.80
-28.14%
Interest
0.00
0.60
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
576.50
623.20
-7.49%
Operating Profit Margin (Excl OI)
173.00%
231.30%
-5.83%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -8.77% vs 58.54% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -7.49% vs 130.13% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
7,491.40
7,890.40
-5.06%
Operating Profit (PBDIT) excl Other Income
1,662.90
2,285.80
-27.25%
Interest
21.70
61.00
-64.43%
Exceptional Items
-20.50
-31.10
34.08%
Consolidate Net Profit
1,804.30
2,376.50
-24.08%
Operating Profit Margin (Excl OI)
184.40%
256.40%
-7.20%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -5.06% vs 12.22% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -24.08% vs 51.11% in Dec 2023
About Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. 
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






